{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T01:52:21Z","timestamp":1783389141995,"version":"3.54.6"},"reference-count":35,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"US Environmental Protection Agency"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxics"],"abstract":"<jats:p>Various PFAS have been identified as potential endocrine-disrupting chemicals due to estrogen receptor activation, impacts on puberty timing, or impacts on hormonally sensitive endpoints in fish. This study screened multiple PFAS in the rat uterotrophic assay to determine potential estrogenic effects on the uterus with PFAS exposure. This study also explored PFAS-dependent uterine signaling with an osmotic stress mRNA gene expression array. Briefly, Sprague\u2013Dawley rats (26\u201339 days old) were ovariectomized, and uterine tissue was allowed to regress for a 3-week period of recovery. Animals were then exposed daily via oral gavage to PFAS for 4 days, and then uterine weight was determined. In contrast to the positive control estrogens, the PFAS tested (4:2, 6:2, and 8:2FTOH; perfluorooctanesulfonamide (PFOSA), perfluorononanoic acid (PFNA), perfluorohexane sulfonate (PFHxS), perfluorooctane sulfonate (PFOS), nafion byproduct 2 (NBP2), 1H,1H,8H,8H-perfluorooctane-1,8-diol (FC8-diol) and 1H,1H,10H,10H-perfluorodecane-1,10-diol (FC10-diol)) caused no significant changes in the uterine weight. Hormonally active compounds can act as carcinogens, and because earlier rodent work has demonstrated that chronic PFOA exposure is associated with increased risk of uterine cancer, uterine mRNA gene expression was explored with an osmotic stress RT-qPCR array. PFAS exposure significantly upregulated multiple genes across the array, with PFOSA being the compound most similar to the reference estrogens (estradiol benzoate and ethinyl estradiol) in its expression pattern. Also, across all PFAS, pathway analysis revealed that the paxillin pathway, a pathway important in tumor suppressor gene SHP-2 signaling, was significantly upregulated with PFAS exposure. These results demonstrate that in vitro estrogen screens or impacts in fish may show different responses from direct impacts on mammalian uterine weight as assessed with the uterotrophic assay. This study also builds out new mechanisms that may contribute to understanding of carcinogenic changes seen in the uterus after PFAS exposure.<\/jats:p>","DOI":"10.3390\/toxics12030170","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T04:31:23Z","timestamp":1708662683000},"page":"170","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["PFAS Modulate Osmotic Signaling Independent of Gravimetric Changes in the Rat Uterus"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9668-9070","authenticated-orcid":false,"given":"Aaron","family":"Dixon","sequence":"first","affiliation":[{"name":"Reproductive and Developmental Toxicology Branch, Public Health Integrated Toxicology Division, Center for Public Health and Environmental Assessment, Office of Research and Development, United States Environmental Protection Agency, Research Triangle Park, NC 27711, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn G.","family":"Rowan","sequence":"additional","affiliation":[{"name":"Oak Ridge Institute for Science and Education, U.S. Department of Energy, Oak Ridge, TN 37831, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison N.","family":"Yackley","sequence":"additional","affiliation":[{"name":"Oak Ridge Institute for Science and Education, U.S. Department of Energy, Oak Ridge, TN 37831, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2458-6267","authenticated-orcid":false,"given":"Erin P.","family":"Hines","sequence":"additional","affiliation":[{"name":"Reproductive and Developmental Toxicology Branch, Public Health Integrated Toxicology Division, Center for Public Health and Environmental Assessment, Office of Research and Development, United States Environmental Protection Agency, Research Triangle Park, NC 27711, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jsbmb.2011.03.011","article-title":"Endocrine disrupting properties of perfluorooctanoic acid","volume":"127","author":"White","year":"2011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"116136","DOI":"10.1016\/j.taap.2022.116136","article-title":"In vitro activity of a panel of per- and polyfluoroalkyl substances (PFAS), fatty acids, and pharmaceuticals in peroxisome proliferator-activated receptor (PPAR) alpha, PPAR gamma, and estrogen receptor assays","volume":"449","author":"Evans","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"152789","DOI":"10.1016\/j.tox.2021.152789","article-title":"Bioactivity profiling of per- and polyfluoroalkyl substances (PFAS) identifies potential toxicity pathways related to molecular structure","volume":"457","author":"Houck","year":"2021","journal-title":"Toxicology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"14514","DOI":"10.1021\/acs.est.0c03468","article-title":"Evaluation of the Estrogenic\/Antiestrogenic Activities of Perfluoroalkyl Substances and Their Interactions with the Human Estrogen Receptor by Combining In Vitro Assays and In Silico Modeling","volume":"54","author":"Li","year":"2020","journal-title":"Environ. Sci. Technol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/toxsci\/kfn099","article-title":"Effects of perfluorobutyrate exposure during pregnancy in the mouse","volume":"105","author":"Das","year":"2008","journal-title":"Toxicol. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.reprotox.2014.12.012","article-title":"Developmental toxicity of perfluorononanoic acid in mice","volume":"51","author":"Das","year":"2015","journal-title":"Reprod. Toxicol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1021\/acs.est.2c09315","article-title":"Verification of In Vivo Estrogenic Activity for Four Per- and Polyfluoroalkyl Substances (PFAS) Identified as Estrogen Receptor Agonists via New Approach Methodologies","volume":"57","author":"Villeneuve","year":"2023","journal-title":"Environ. Sci. Technol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.taap.2007.09.023","article-title":"Toxicogenomic analysis of the hepatic effects of perfluorooctanoic acid on rare minnows (Gobiocypris rarus)","volume":"226","author":"Wei","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.aquatox.2007.09.009","article-title":"Evaluation of estrogenic activities and mechanism of action of perfluorinated chemicals determined by vitellogenin induction in primary cultured tilapia hepatocytes","volume":"85","author":"Liu","year":"2007","journal-title":"Aquat. Toxicol."},{"key":"ref_10","unstructured":"(2024, January 01). National Toxicology Program. Technical Report on the Toxicology and Carcinogenesis Studies of Perfluorooctanoic Acid (CASRN 335-67-1) Administered in Feed to Sprague Dawley (Hsd:Sprague Dawley\u00ae SD\u00ae) Rats (Revised) NTP TR 598 May 2020, Revised February 2023, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560147\/."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.reprotox.2016.08.009","article-title":"Perfluoroalkyl substances and endometriosis in US women in NHANES 2003\u20132006","volume":"65","author":"Campbell","year":"2016","journal-title":"Reprod. Toxicol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"106819","DOI":"10.1016\/j.envint.2021.106819","article-title":"Perfluoroalkyl substances (PFAS) in drinking water and risk for polycystic ovarian syndrome, uterine leiomyoma, and endometriosis: A Swedish cohort study","volume":"157","author":"Hammarstrand","year":"2021","journal-title":"Environ. Int."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"0670","DOI":"10.1289\/EHP1203","article-title":"Plasma perfluoroalkyl and polyfluoroalkyl substances concentration and menstrual cycle characteristics in preconception women","volume":"125","author":"Zhou","year":"2017","journal-title":"Environ. Health Perspect."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.envint.2010.08.007","article-title":"Exposure to polyfluoroalkyl chemicals during pregnancy is not associated with offspring age at menarche in a contemporary British cohort","volume":"37","author":"Christensen","year":"2011","journal-title":"Environ. Int."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.envres.2015.12.037","article-title":"Perfluorooctanoic acid exposure and natural menopause: A longitudinal study in a community cohort","volume":"146","author":"Dhingra","year":"2016","journal-title":"Environ. Res."},{"key":"ref_16","unstructured":"Zahm, S. Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid, Lancet Oncol., in press."},{"key":"ref_17","unstructured":"(2024, January 01). POPS Listed in the Stockholm Convention. Available online: https:\/\/www.pops.int\/TheConvention\/ThePOPs\/AllPOPs\/tabid\/2509\/Default.aspx."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1177\/0748233718799191","article-title":"Genotoxicity assessment of perfluoroalkyl substances on human sperm","volume":"34","author":"Emerce","year":"2018","journal-title":"Toxicol. Ind. Health"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ijheh.2011.05.010","article-title":"Impacts of two perfluorinated compounds (PFOS and PFOA) on human hepatoma cells: Cytotoxicity but no genotoxicity?","volume":"214","author":"Florentin","year":"2011","journal-title":"Int. J. Hyg. Environ. Health"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s00204-016-1836-2","article-title":"Identification of protein tyrosine phosphatase SHP-2 as a new target of perfluoroalkyl acids in HepG2 cells","volume":"91","author":"Yang","year":"2017","journal-title":"Arch. Toxicol."},{"key":"ref_21","unstructured":"United States Environmental Protection Agency (2011). Uterotrophic Assay OCSPP Guideline 890.1600: Standard Evaluation Procedure (SEP)."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.reprotox.2011.10.011","article-title":"Histopathologic changes in the uterus, cervix and vagina of immature CD-1 mice exposed to low doses of perfluorooctanoic acid (PFOA) in a uterotrophic assay","volume":"33","author":"Dixon","year":"2012","journal-title":"Reprod. Toxicol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Prokai, L., Rahlouni, F., Zaman, K., Nguyen, V., and Prokai-Tatrai, K. (2021). Proteomics Complementation of the Rat Uterotrophic Assay for Estrogenic Endocrine Disruptors: A Roadmap of Advancing High Resolution Mass Spectrometry-Based Shotgun Survey to Targeted Biomarker Quantifications. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041686"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.2337\/diabetes.50.2007.S150","article-title":"Compensatory responses in mice carrying a null mutation for Ins1 or Ins2","volume":"50","author":"Leroux","year":"2001","journal-title":"Diabetes"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1289\/ehp.10334","article-title":"Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth","volume":"115","author":"Apelberg","year":"2007","journal-title":"Environ. Health Perspect."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"107631","DOI":"10.1016\/j.envint.2022.107631","article-title":"Environment International, Cumulative maternal and neonatal effects of combined exposure to a mixture of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS)","volume":"170","author":"Conley","year":"2022","journal-title":"Environ. Int."},{"key":"ref_27","unstructured":"(2023, August 01). Per- and Polyfluoroalkyl Substances (PFAS) and Your Health, ATSDR\/CDC, Available online: https:\/\/www.atsdr.cdc.gov\/pfas\/health-effects\/index.html."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41370-023-00529-x","article-title":"Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden","volume":"33","author":"Dunder","year":"2023","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41370-022-00464-3","article-title":"Association between per- and polyfluoroalkyl substances exposure and risk of diabetes: A systematic review and meta-analysis","volume":"33","author":"Gui","year":"2023","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"965384","DOI":"10.3389\/fendo.2022.965384","article-title":"Exposure to per- and polyfluoroalkyl substances (PFAS) and type 2 diabetes risk","volume":"13","author":"Roth","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/jcmm.12618","article-title":"Functions of Shp2 in cancer","volume":"19","author":"Zhang","year":"2015","journal-title":"J. Cell Mol. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"66558","DOI":"10.18632\/oncotarget.11684","article-title":"Perfluorooctanoic acid induces human Ishikawa endometrial cancer cell migration and invasion through activation of ERK\/mTOR signaling","volume":"7","author":"Ma","year":"2016","journal-title":"Oncotarget"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1124\/pr.108.000869","article-title":"SLC6 neurotransmitter transporters: Structure, function, and regulation","volume":"63","author":"Kristensen","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2217\/bmm-2018-0256","article-title":"Elevated SLC6A6 expression drives tumorigenesis and affects clinical outcomes in gastric cancer","volume":"13","author":"Dazhi","year":"2019","journal-title":"Biomark. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.mam.2012.07.002","article-title":"SLC6 Transporters: Structure, Function, Regulation, Disease Association and Therapeutics","volume":"34","author":"Pramod","year":"2013","journal-title":"Mol. Aspects Med."}],"container-title":["Toxics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2305-6304\/12\/3\/170\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:03:31Z","timestamp":1760105011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2305-6304\/12\/3\/170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,23]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["toxics12030170"],"URL":"https:\/\/doi.org\/10.3390\/toxics12030170","relation":{},"ISSN":["2305-6304"],"issn-type":[{"value":"2305-6304","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,23]]}}}